<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Inspire Pharmaceuticals Inc. | Company News & Executive Profiles - ISPH | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Inspire Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="46" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152932-inspire-pharmaceuticals-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Inspire Pharmaceuticals, Inc. ISPH   Q2 2009 Earnings Call   July 31, 2009 10:00 am ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 31 Jul 2009 11:46:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-327153.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of David Amsellem with Piper Jaffray. David Amsellem - Piper Jaffray  Hi, thanks. Just a quick question on denufosol. Can you talk about what if any new data you may be presenting at the North American CF...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 31 Jul 2009 10:46:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/partnership.html"><![CDATA[Partnership]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+bancorp+piper+jaffray+inc..html"><![CDATA[U.S. Bancorp Piper Jaffray Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharma Still Looks Good After Earnings]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F137739-inspire-pharma-still-looks-good-after-earnings%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zacks.com submits:   By Grant Zeng, CFA Late last week, Inspire Pharmaceuticals Inc. ISPH reported first quarter 2009 financial results ended March 31, 2009, which were in line with our expectations see conference call transcript. by Zacks.com]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 14 May 2009 09:13:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zacks.com.html"><![CDATA[Zacks.com]]></category>
		<category domain="http://resources.bnet.com/topic/allergan+inc..html"><![CDATA[Allergan Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">AGN,ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-300207.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Thank you, sir. Operator instructions Your first question comes from the line of Liana Moussatos with Wedbush. Liana Moussatos &#8211; Wedbush Morgan What was the non-cash stock option expense in Q1? Tom Staab Liana, I don&#8217;t have that number on my &#8211; at my fingertips, but typical...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 May 2009 04:48:16 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/restructuring.html"><![CDATA[Restructuring]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/quarter.html"><![CDATA[Quarter]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Inc. F4Q and Full Year 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-275019.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Liana Moussatos of Wedbush Morgan. Liana Moussatos - Wedbush Morgan  Could you repeat the quarter-over-quarter AzaSite sales and prescription growth and then what was the stock based compensation amount?  Also, how many potential partners are in discussion...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 03 Mar 2009 12:30:41 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/commercialization.html"><![CDATA[Commercialization]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[Stock]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/elestat.html"><![CDATA[Elestat]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/benefits.html"><![CDATA[Benefits]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-245507.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator  At this time, Operator Instructions.  Your first question comes from the line of Eric Varma with Leerink Swann.   Eric Varma - Leerink Swann  Hi, great job on earnings this morning.  This is Eric Varma in place of Joe Schwartz. ...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 31 Oct 2008 11:45:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/europe.html"><![CDATA[Europe]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/north+america.html"><![CDATA[North America]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/u.s..html"><![CDATA[U.S.]]></category>
		<category domain="http://resources.bnet.com/topic/dr..html"><![CDATA[Dr.]]></category>
		<category domain="http://resources.bnet.com/topic/europe.html"><![CDATA[Europe]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/north+america.html"><![CDATA[North America]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Pharmaceuticals, Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224229.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions. Your first question comes from the line of Joseph Schwartz with Leerink Swann. Joseph Schwartz - Leerink Swann Hi. Good morning. Congratulations on all the progress. I was wondering, first on denufosol, did you actually hold a meeting with the FDA and discuss whether the...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 11 Aug 2008 12:31:16 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Announces Peer-Reviewed Publications Related to Denufosol for Cystic Fibrosis]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_August_6/ai_n27971408]]></link>
		<description><![CDATA[DURHAM, N.C. -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today publication of two papers related to the denufosol for cystic fibrosis development program in peer-reviewed journals.  The first paper, "Denufosol: A Review of Studies with Inhaled P2Y2 Agonists that led to Phase 3" (D. Kellerman, A. Rossi Mospan, J....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 06 Aug 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire Announces Webcast of Presentation at Piper Jaffray Europe Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_June_18/ai_n27501936]]></link>
		<description><![CDATA[DURHAM, N.C. -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO of Inspire, will present at the Piper Jaffray Europe Conference on Wednesday, June 25, 2008 at 10:40 am GMT in London, England.  The webcast of the presentation will be available on...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 18 Jun 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+bancorp+piper+jaffray+inc..html"><![CDATA[U.S. Bancorp Piper Jaffray Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
	<item>
		<title><![CDATA[Inspire to Discontinue Development of Epinastine Nasal Spray]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_23/ai_n25342473]]></link>
		<description><![CDATA[DURHAM, N.C. -- Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that its Phase 3 trial with epinastine nasal spray for the treatment of seasonal allergic rhinitis SAR did not meet its primary endpoint.  "Our analysis of the overall data in this program and the current competitive environment in allergic...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 23 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/endpoint.html"><![CDATA[endpoint]]></category>
		<category domain="http://resources.bnet.com/topic/inspire+pharmaceuticals+inc..html"><![CDATA[Inspire Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sec.html"><![CDATA[SEC]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ISPH</category>
		<category domain="tickers">ISPH</category>
	</item>
</channel>
</rss>
